Your browser doesn't support javascript.
loading
Impact of switching from triple therapy to dual bronchodilation in COPD: the DACCORD 'real world' study.
Vogelmeier, Claus F; Worth, Heinrich; Buhl, Roland; Criée, Carl-Peter; Gückel, Eva; Kardos, Peter.
Afiliação
  • Vogelmeier CF; Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Centre Giessen and Marburg, Philipps-University Marburg, Member of the German Centre for Lung Research (DZL), 35043, Marburg, Germany. Claus.Vogelmeier@med.uni-marburg.de.
  • Worth H; Facharztforum Fürth, 90762, Fürth, Germany.
  • Buhl R; Pulmonary Department, Mainz University Hospital, 55131, Mainz, Germany.
  • Criée CP; Department of Sleep and Respiratory Medicine, Evangelical Hospital Goettingen-Weende, 37120, Bovenden, Germany.
  • Gückel E; Clinical Research, Respiratory, Novartis Pharma GmbH, 90429, Nürnberg, Germany.
  • Kardos P; Group Practice and Centre for Allergy, Respiratory and Sleep Medicine, Red Cross Maingau Hospital, 60316, Frankfurt am Main, Germany.
Respir Res ; 23(1): 109, 2022 May 02.
Article em En | MEDLINE | ID: mdl-35501806
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença Pulmonar Obstrutiva Crônica / Agonistas de Receptores Adrenérgicos beta 2 Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Respir Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença Pulmonar Obstrutiva Crônica / Agonistas de Receptores Adrenérgicos beta 2 Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Respir Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha